Discontinued — last reported Q4 '22
Elevance Health Other Segment — Reportable segments operating revenues increased by 1.3% to $3.41B in Q4 2022 compared to the prior quarter. Year-over-year, this metric grew by 26.6%, from $2.69B to $3.41B. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in operating revenues indicates successful expansion or increased market share within the segment's specific product offerings.
This metric aggregates the total operating revenue generated by the Other segment. It reflects the top-line performance...
Standard segment-level revenue reporting required for public companies under GAAP/IFRS.
elv_segment_other_segment_reportable_segments_operating_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | |
|---|---|---|---|---|---|---|---|
| Value | $2.52B | $2.67B | $2.69B | $3.22B | $3.30B | $3.37B | $3.41B |
| QoQ Change | — | +6.1% | +0.9% | +19.6% | +2.4% | +2.0% | +1.3% |
| YoY Change | — | — | — | — | +31.0% | +26.0% | +26.6% |